- Trials with a EudraCT protocol (22)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
22 result(s) found for: Unilateral Hearing Loss.
Displaying page 1 of 2.
EudraCT Number: 2008-000132-40 | Sponsor Protocol Number: AM-111-CL-08-01 | Start Date*: 2008-11-18 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Efficacy of AM 111 in Patients with Acute Sensorineural Hearing Loss: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Dose-Escalation Phase II Study | |||||||||||||
Medical condition: Acute sensorineural hearing loss (ASNHL), which may be triggered by acoustic trauma, middle or inner ear surgery, i.e. known or evident insults to the inner ear. ASNHL may also result from a variet... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000658-20 | Sponsor Protocol Number: 7621 | Start Date*: 2017-04-24 |
Sponsor Name: | ||
Full Title: Combinated systemic and intratympanic steroid therapy in idiopathic sudden sensorineural hearing loss | ||
Medical condition: Idiopathic Sudden Sensorineural Hearing Loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003268-29 | Sponsor Protocol Number: OTI2013 | Start Date*: 2013-10-17 |
Sponsor Name:AUSL Piacenza | ||
Full Title: Hyperbaric oxygen therapy in the treatment of sudden hydiopatic sensorineural hearing loss | ||
Medical condition: Sudden Sensorineural Hearing Loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000242-22 | Sponsor Protocol Number: STR001-202 | Start Date*: 2017-06-28 | |||||||||||
Sponsor Name:STREKIN AG | |||||||||||||
Full Title: A Phase III multicenter, double-blind, placebo-controlled, study evaluating the safety, and efficacy of STR001 treatment in adults with Sudden Sensorineural Hearing Loss | |||||||||||||
Medical condition: Sudden Sensorineural Hearing Loss (SSHL) including - idiopathic unilateral Sensorineural Hearing Loss - acute uni- or bilateral acoustic trauma-induced Sensorineural Hearing Loss | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) CZ (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002602-36 | Sponsor Protocol Number: KKSH-127 | Start Date*: 2016-06-21 |
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | ||
Full Title: Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss (HODOKORT) | ||
Medical condition: Idiopathic sudden sensorineural hearing loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000066-37 | Sponsor Protocol Number: NM-V-101 | Start Date*: 2013-01-16 | |||||||||||
Sponsor Name:Nordmark Arzneimittel GmbH & Co. KG | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled study on efficacy, safety and tolerability of ancrod in patients with sudden sensorineural hearing loss | |||||||||||||
Medical condition: sudden sensorineural hearing loss (SSHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000812-47 | Sponsor Protocol Number: SENS401-201 | Start Date*: 2018-10-11 | |||||||||||
Sponsor Name:SENSORION SA | |||||||||||||
Full Title: A two- part, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of SENS-401 in subjects with severe or profound sudden sensorineural hearing loss | |||||||||||||
Medical condition: Sudden sensorineural hearing loss (SSNHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) GB (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005166-58 | Sponsor Protocol Number: AM-111-CL-15-01 | Start Date*: 2017-10-12 | |||||||||||
Sponsor Name:Auris Medical Inc. | |||||||||||||
Full Title: Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment (ASSENT) | |||||||||||||
Medical condition: Idiopathic sudden sensorineural hearing loss. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004803-78 | Sponsor Protocol Number: 1.1 | Start Date*: 2009-03-20 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Effectiveness of Transtympanic Steroids in unilateral Ménière's disease: a Randomised Controlled Double-Blind Trial | |||||||||||||
Medical condition: refractory unilateral Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002077-21 | Sponsor Protocol Number: AM-111-CL-13-01 | Start Date*: 2015-10-15 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Efficacy and Safety of AM-111 in the Treatment of Acute Inner Ear Hearing Loss | |||||||||||||
Medical condition: Idiopathic sudden sensorineural hearing loss | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) HU (Completed) ES (Prematurely Ended) DE (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003068-30 | Sponsor Protocol Number: CMV-MM-2 | Start Date*: 2013-09-30 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: CONgenital Cytomegalovirus: Efficacy of antiviral treatment in a non-Randomized Trial with historical control group | |||||||||||||
Medical condition: Congenital cytomegalovirus infection. Sensorineural Hearingloss. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005378-44 | Sponsor Protocol Number: CMV-MM-1 | Start Date*: 2012-05-03 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: CONgenital Cmv: Efficacy of antiviral treatment in a Randomized controlled Trial | |||||||||||||
Medical condition: Congenital cytomegalovirus infection. Sensorineural Hearingloss. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001464-35 | Sponsor Protocol Number: 104-201811 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:Otonomy, Inc. | |||||||||||||
Full Title: A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere’... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002261-18 | Sponsor Protocol Number: M05-2013 | Start Date*: 2013-08-21 |
Sponsor Name:Synphora AB | ||
Full Title: A randomized, double-blind, placebo-controlled, parallel group study to determine the efficacy, the duration of action, and safety of latanoprost in patients with Menière’s disease | ||
Medical condition: Menière´s disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004496-71 | Sponsor Protocol Number: 104-201508 | Start Date*: 2016-03-01 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere’... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001337-86 | Sponsor Protocol Number: 104-201403 | Start Date*: 2014-07-11 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A 6-month, prospective, randomized, multicenter, placebo-controlled safety study of OTO-104 given at 3-month intervals by intratympanic injection in subjects with unilateral Meniere's disease, foll... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000766-29 | Sponsor Protocol Number: 104-201610 | Start Date*: 2016-07-29 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A 6-MONTH, MULTICENTER, PHASE 3, OPEN-LABEL EXTENSION SAFETY STUDY OF OTO-104 GIVEN AT 3-MONTH INTERVALS BY INTRATYMPANIC INJECTION IN SUBJECTS WITH UNILATERAL MENIERE’S DISEASE | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005913-37 | Sponsor Protocol Number: no sponsor | Start Date*: 2009-03-09 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Intratympanic gentamicin therapy for M Meniere: a comparison of two regimes | |||||||||||||
Medical condition: Patients suffering of Menieres disease for at least 6 moths without sufficient relief of symptoms through medicinal therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002692-41 | Sponsor Protocol Number: AM-101-AAT-PHA1 | Start Date*: 2006-09-15 | |||||||||||
Sponsor Name:Laboratoires Auris SAS | |||||||||||||
Full Title: Safety of AM-101 in Patients with Acute Inner Ear Tinnitus from Noise Trauma: a Dose-Finding Phase I/II Study | |||||||||||||
Medical condition: Inner ear tinnitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003635-10 | Sponsor Protocol Number: 2814 | Start Date*: 2018-05-23 |
Sponsor Name:University of Bristol | ||
Full Title: Immediate oral, immediate topical or delayed oral antibiotics for acute otitis media with discharge (the Runny Ear STudy: REST) | ||
Medical condition: Acute Otitis Media with discharge | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
